Search for: "Apotex Inc."
Results 481 - 500
of 674
Sort by Relevance
|
Sort by Date
15 Feb 2010, 8:11 am
" In re Pfizer Inc., Misc. [read post]
10 Feb 2010, 4:47 pm
Tolmar Inc. [read post]
3 Feb 2010, 2:00 am
Johnson & Johnson Inc. et al. [read post]
19 Jan 2010, 12:00 am
Inc) sued Apotex for infringing three patents related to Nasonex nasal spray by submitting an ANDA for permission to market and distribute a generic version of Nasonex® . [read post]
14 Jan 2010, 11:09 am
Apotex Corp., 316 F.3d 1348, 1365 (Fed. [read post]
12 Jan 2010, 7:26 am
Apotex, Inc., 623 F.Supp.2d 579, 598-600 (D.N.J.2009); Alza Corp. v. [read post]
27 Dec 2009, 8:32 pm
KG • Defendants: Apotex Inc.; Apotex Corp. [read post]
22 Dec 2009, 10:33 am
Apotex Corp. decides which of Apotex Inc. [read post]
16 Dec 2009, 3:39 am
: Ariad Pharmaceuticals, Inc. v. [read post]
1 Dec 2009, 9:45 am
Apotex Corporation and Apotex Inc. [read post]
30 Nov 2009, 12:00 am
Budejovicky Budvar Narodni Podnik v Anheuser-Busch Inc (Class 46) (IPKat) EPO: Should green technology be subject to compulsory licensing? [read post]
18 Nov 2009, 4:57 am
Apotex Inc. et al. [read post]
18 Nov 2009, 4:57 am
Apotex Inc. et al. [read post]
18 Nov 2009, 4:57 am
Apotex Inc. et al. [read post]
12 Nov 2009, 9:17 am
Apotex, Inc., 432 F. [read post]
8 Nov 2009, 9:28 pm
• Defendants: Apotex Inc.; Apotex Corp. [read post]
2 Nov 2009, 1:20 pm
’s judgment for the Court in Apotex Inc. v. [read post]
29 Oct 2009, 11:11 am
Opinion below (9th Circuit) Petition for certiorari Brief in opposition Petitioner’s reply Docket: 09-117 Title: Apotex, Inc. v. [read post]
27 Oct 2009, 8:49 am
(NYSE:AGN) a victory last week in its patent infringement lawsuit brought against Exela PharmSci, Inc., Exela PharmSci Pvt., Ltd., Apotex, Inc. and Apotex Corp. [read post]
14 Oct 2009, 7:00 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: Angiomax (Bivalirudin) – US: Medicines Company files patent infringement suit against PLIVA, Barr, Teva following Para IV challenge (Patent Docs) (America-Israel Patent Law) (The IP Factor) (GenericsWeb) Humira (Adalimumab) – US: E D Texas find ‘close issue of claim construction’ supports JMOL of no… [read post]
